Recurrent respiratory papillomatosis: Altered CD8+ T-cell subsets and T(H)1/T(H)2 cytokine imbalance

Clinical Immunology

Volumn 93, Issue 3, 1999, Pages 302-311

  Bonagura, Vincent R ^a   Hatam, Lynda ^a   Devoti, James ^a   Zeng, Feifei ^a   Steinberg, Bettie M ^b  

^a SCHNEIDER CHILDREN'S HOSPITAL   (United States)

^b LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

CD8+ T cells; Cytokines; Papillomas

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CYTOKINE RELEASE; FEMALE; HUMAN; LYMPHOCYTE CULTURE; MALE; MORBIDITY; MORTALITY; PAPILLOMATOSIS; PRIORITY JOURNAL; RECURRENT DISEASE; RESPIRATORY TRACT DISEASE; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE SUBPOPULATION;

EID: 0032787403     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.1999.4784     Document Type: Article

References (58)

1. Holinger P., Johnson K., Anison G. Papilloma of the larynx: Review of 109 cases with preliminary report of aureomycin therapy. Ann. Otol. Rhinol. Laryngol. 59:1950;547-563.
2. Mounts P., Shah K. V., Kashima H. Viral etiology of juvenile and adult-onset squamous papilloma of the larynx. Proc. Natl. Acad. Sci. USA. 79:1982;5425-5429.
3. Gissman L., Wolnik L., Ikenberg H., Koldovsky U., Schnurch H. G., zur Hausen H. Human papillomavirus 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc. Natl. Acad. Sci. USA. 80:1983;560-563.
4. Brandsma J., Abramson A. Association of papillomavirus with cancers of the head and neck. Arch. Otolaryngol. Head Neck Surg. 115:1989;621-625.
5. Abramson A., Steinberg B., Winkler B. Laryngeal papillomatosis: Clinical, histopathologic and molecular studies. Laryngoscope. 97:1987;678-684.
6. Steinberg B., Gallagher T., Stoler M., Abramson A. Persistence and expression of human papillomavirus during interferon therapy. Arch. Otolaryngol. Head Neck Surg. 90:1988;728-735.
7. Bonnez W., Kashima H., Leventhal B., Mounts P., Rose R., Reichman R., Shah K. Antibody response to human papillomavirus (HPV type 11 in children with juvenile-onset recurrent respiratory papillomatosis (RRP). Virology. 188:1992;384-387.
8. Christensen N., Kreider J. Antibody-mediated neutralization in vivo of infectious papillomaviruses. J. Virol. 64:1990;3151-3156.
9. Naiman H., Ruben R., Doyle A., Kadish A. Natural cytotoxicity and interferon production in patients with recurrent respiratory papillomatosis. Ann. Otol. Rhinol. Laryngol. 93:1984;483-487.
10. Jakubikova J., Oravec C., Klacansky I. Modulation of humoral and cellular resistance in children with laryngeal papillomatosis. Int. J. Ped. Otorhinolaryngol. 23:1992;229-236.
11. Kircher H. Immunobiology and human papillomavirus infection. Prog. Med. Virol. 33:1986;1-41.
12. Townsend A., Bodmer H. Antigen recognition by class I restricted T lymphocytes. Ann. Rev. Immunol. 7:1989;601-624.
13. June C., Ledbetter J., Linsley P., Thompson C. Role of the CD28 receptor in T-cell activation. Immunol. Today. 11:1990;211-216.
14. Lum L., Orcutt-Thordarson N., Seigneuret M., Hansen J. In vitro regulation of immunoglobulin synthesis by T-cell subpopulations defined by a new human T-cell antigen. Cell. Immunol. 72:1980;122-129.
15. Damle N., Mohagheghpour N., Hansen J., Engleman E. Alloantigen-specific cytotoxic and suppressor T lymphocytes are derived from phenotypically distinct precursors. J. Immunol. 131:1983;2296-2300.
16. - T lymphocytes antigenic and functional properties. J. Immunol. 150:1993;1147-1159.
17. Arai K., Lee F., Myajima A., Miyatake S., Arai S., Yokota T. Cytokines: Coordinators of immune and inflammatory responses. Ann. Rev. Biochem. 59:1990;783-836.
18. Taga T., Kishimoto T. Signaling mechanisms through cytokine receptors that share signal transduction receptor components. Curr. Opin. Immunol. 7:1995;17-23.
19. Sadick M., Heinzel F., Holaday B., Pu R., Dawkins R., Locksley R. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody: Evidence for a T-cell dependent, interferon independent mechanism. J. Exp. Med. 171:1991;115-127.
20. Pearce E., Caspar P., Grzych J., Lewis F., Sher A. Down-regulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth. Schistosoma mansoni, J. Exp. Med. 173:1991;159-166.
21. Fiorentino D., Bond M., Mosmann T. Two types of mouse helper T cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170:1989;2081-2095.
22. Locksley R., Scott P. Helper-T cell subsets in mouse leishmaniasis: Induction and effector function. Ash C., Gallagher R. B. Immunoparasitology Today. 1991;A58 Elsevier, Cambridge.
23. Romagnani S. The Th1/Th2 paradigm. Immunol. Today. 18:1997;263-266.
24. + T cells in human disease: lymphokine patterns in leprosy. Chem. Immunol. 55:1992;44-59.
25. Parronchi P., Macchia D., Piccinni M., Biswas P., Simonelli C., Maggi E., Ricci M., Asari A., Romagnani S. Allergen and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. Proc. Natl. Acad. Sci. USA. 88:1991;4538-4542.
26. Romagnani S. Th1 and Th2 in human disease. Clin. Immunol. Immunopathol. 80:1996;225-235.
27. Salgame P., Abrams J., Clayberger C., Goldstein H., Modlin R., Convit J., Bloom B. R. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T-cell clones. Science. 254:1991;279-282.
28. Tada T., Ohzeki S., Utsumi K., Takiuchi H., Muramatsu M., Li X., Shimizu J., Fujiwara H., Hamaoka T. Transforming growth factor-β-induced inhibition of T cell function. J. Immunol. 146:1991;1077-1082.
29. Bloom B., Modlin R., Salgame P. Stigma variation: Observation on suppressor T-cells and leprosy. Ann. Rev. Immunol. 10:1992;453-488.
30. Rogge L., Barberis-Maino L., Biffi M., Passini N., Presky D., Gubler U., Sinigaglia F. Selective expression of an interleukin-12 receptor component of human T helper 1 cells. J. Exp. Med. 185:1997;825-831.
31. Kashima H., Leventhal B., Mounts P. Scoring system to assess severity and course in recurrent respiratory papillomatosis. Howley H., Broker T. Papillomavirus: Molecular and Clinical Aspects. 1985;125 A. R. Liss, New York.
32. Abramson A. L., Shikowitz M. J., Mullooly V. M., Steinberg B. M., Ameilla C. A., Rothstein H. R. Clinical effects of photodynamic therapy on recurrent laryngeal papillomas. Arch. Otolaryngol. Head Neck Surg. 118:1992;25-29.
33. Abramson A. L., Shikowitz M. J., Mullooly V. M., Steinberg B. M., Hyman R. B. Variable light-dose effect on photodynamic therapy for laryngeal papillomas. Arch. Otolaryngol. Head Neck Surg. 120:1994;852-855.
34. Bonagura V. R., Cunningham-Rundles S., Edwards B. L., Ilowite N. T., Wedgwood J. F., Valacer D. J. Common variable hypogammaglobulinema, recurrent Pneumocystis carinii pneumonia on intravenous γ-globulin therapy and natural killer deficiency. Clin. Immunol. Immunopathol. 51:1989;216-231.
35. Wedgwood J. F., Hatam L., Bonagura V. R. Effect of Interferon-γ and tumor necrosis factor on the expression of class I and class II major histocompatibility molecules by cultured human umbilical vein endothelial cells. Cell. Immunol. 111:1988;1-9.
36. Fujita T., Nishi-Takaoka C., Soito A., Motsumoto T., Soto M., Oka T., Itoh S., Yip Y., Vilcek J. Cloning and expression of a novel variant of human interferon-gamma cDNA. J. Biochem. 97:1985;153-159.
37. Yokota T., Otsuka T., Mosmann T., Banchereau J., DeFrance T., Blanchard D., DeVries J., Lee F., Arai K. Isolation and characterization of a human interleukin cDNA clone, homologous to mouse B-cell stimulatory factor 1, that expresses B-cell- and T-cell-stimulating activities. Proc. Natl. Acad. Sci. USA. 83:1986;5894-5898.
38. Viera P., Waal-Malefyt R., Dang M., Johnson K., Kastelein R., Fiorentino D., DeVries J., Roncarolo M., Mosmann T., Moore K. Isolation and expression of human cytokine synthesis inhibitory factor cDNA clone: Homology to Epstein-Barr virus open reading frame BCRFI. Proc. Natl. Acad. Sci. USA. 88:1991;1172-1176.
39. Derynck R., Jarrett J. A., Chen E. Y., Eaton D. H., Bell J. R., Assoian R. K., Robberts A. B., Sporn M. B., Goeddel D. V. Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature. 316:1985;701-704.
40. Bonagura V., Siegal F., Abramson A., Santiago-Schwartz F., O-Reilly M. E., Shah K., Drake D., Steinberg B. M. Enriched HLA-DQ3 phenotype and decreased class I major histocompatibility complex antigen expression in recurrent respiratory papillomatosis. Clin. Diagn. Lab. Immunol. 1:1994;357-360.
41. + T-cells. J. Immunol. 158:1997;1551-1558.
42. - T lymphocytes. J. Immunol. 150:1993;1147-1159.
43. + T cells in health and disease: Aging, infection, or immune regulation? Hum. Immunol. 48:1996;68-76.
44. + counterparts. J. Immunol. 156:1996;3587-3590.
45. Szabo S., Dighe A., Gubler U., Murphy K. Regulation of the interleukin (IL)-12R β2 subunit expression in developing T helper (Th1) and (Th2) cells. J. Exp. Med. 185:1997;817-824.
46. D'Andrea A., Aste-Amezaga M., Valianate N. M., Ma X., Kubin M., Trinchieri G. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178:1993;1041-1048.
47. Micallef M. J., Ohtsuki T., Kohno K., Tanabe F., Ushio S., Namba M., Tanimoto T., Torigoe K., Fujii M., Ikeda M., Fukuda S., Kurimoto M. Interferon gamma inducing factor enhances T helper 1 cytokine production by stimulated human T-cells: Synergism with interleukin 12 for interferon-gamma production. Eur. J. Immunol. 26:1996;1647-1651.
48. Schwartz T., Urbanski A., Luger T. A. Ultraviolet light and epidermal cell-derived cytokines. Luger T. A., Schwartz T. Epidermal Growth Factors and Cytokine. 1994;303-324 Dekker, New York.
49. Thivolet J., Hegazy M. R., Viac J., Chardonnet Y. An in vitro study of cell mediated immunity in human warts. Derm. Vener. Stockh. 57:1977;317-317.
50. Mathews R., Shirodaria P. Study of regressing warts by immunofluorescence. Lancet. 1:1977;689-691.
51. Majewski S., Jablonska S. Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancers: The role of local immunosurveillance. Am. J. Med. Sci. 304:1992;174-179.
52. Kasmima H., Leventahal B., Clark K., Cohen S., Debo H., Donovan D., Fearon B., Gardiner L., Goepfert H., Lusk R., McCabe B., Mounts P., Muntz H., Richardson M., Singleton G., Weck P., Whisnant J., Wold D., Yonkers A. Interferon α-N1 (Wellferon) in juvenile onset recurrent respiratory papillomatosis: Results of a randomized study of twelve collaborative institutions. Laryngoscope. 98:1988;334-340.
53. Viac J., Thivolet J., Chardonnet Y. Specific immunity in patients suffering from recurring warts before and after repetitive intradermal tests with human papilloma virus. Br. J. Dermatol. 97:1977;365-370.
54. Chardonnet Y., Beauve P., Viac J., Schmitt D. T-cell subsets and Langerhans' cells in wart lesions. Immunol. Lett. 6:1983;191-196.
55. Hong K., Breer C., Ketter N., Van Nest G., Pallard X. Isolation and characterization of human papillomavirus type 6-specific T cells infiltrating genital warts. J. Virol. 71:1997;6427-6432.
56. Arany I., Trying S. Status of local cellular immunity in interferon-responsive and non-responsive human papillomavirus-associated lesions. Sex. Transm. Dis. 23:1996;475-480.
57. DiLorenzo T. P., Steinberg B. M. Differential regulation of human papillomavirus 6 and 11 early promoters in cultured cells derived from laryngeal papillomas. J. Virol. 69:1995;6865-6872.
58. Sasazuki T., Kikuchi I., Hirayama K., Matsushita S., Ohta N., Nishimura Y. HLA-linked immune suppression in humans. Immunol. Suppl. 2:1989;21-24.